Maxime Dely: How Do We Balance Benefit and Risk in Chronic Hematologic Diseases?
Maxime Dely, Therapeutic Solutions Sales Consultant at Terumo Blood and Cell Technologies, shared a post on LinkedIn:
“Repeated transfusions: how do we balance benefit and risk in chronic hematologic diseases?
Every year, thousands of patients live thanks to repeated transfusions… but at what long-term cost?
In many chronic hematologic diseases (sickle cell disease, myelodysplastic syndromes, leukemias), red blood cell concentrates are essential to correct anemia
and maintain quality of life.
However, repeated transfusions carry well – documented risks: alloimmunization, making future transfusions more complex, and iron overload, which can lead to hepatic, cardiac, and endocrine complications that are often underestimated.
Iron chelation therapy then becomes necessary, yet burdensome.
Other challenges also arise, such as delayed hemolytic transfusion reactions, sometimes severe, and variability in transfusion thresholds, raising questions about optimal use.
Current guidelines emphasize a more restrictive and individualized approach, tailored to each patient’s condition and disease.
Transfusion is no longer just a supportive act – it is a true therapeutic lever, requiring careful balance between immediate clinical benefit and long-term impact.
Should we more broadly rethink transfusion strategies to better anticipate their chronic consequences?”
More posts featuring Maxime Dely on Hemostasis Today.
-
Apr 22, 2026, 07:19Sarah Richardson: Bringing Insights from HFA Symposium Back to Real Life
-
Apr 22, 2026, 07:17Karuna Kumar: Interesting Trial from Gambia on Treating Iron Deficiency in Children
-
Apr 22, 2026, 07:12Mary Catherine Moffett: Celebrating 32 Years of Patient-Centered Advocacy with the Hemophilia Federation of America
-
Apr 22, 2026, 07:02Michael Wong: Predicting Blood Clots is a Patient Safety Issue
-
Apr 22, 2026, 07:02Rich Gorman: The Role of Inquiry Findings in Shaping Professional Memory and Learning
-
Apr 22, 2026, 06:01Kathaleen Schnur: Global Perspectives on Psychosocial Support in Hemophilia Care
-
Apr 22, 2026, 05:43Maia Meier: A Journey to Raise Awareness for Women with Bleeding Disorders
-
Apr 22, 2026, 05:41Moustafa Abdou: Diagnostic Challenges in Pediatric Hematology
-
Apr 22, 2026, 04:43Ifeanyichukwu Ifechidere: The Critical Role of Calibrator Specificity in Anticoagulation Monitoring